NCT03320486View on ClinicalTrials.gov

Non-inferiority Trial of Dapaconazole Versus Ketoconazole

PHASE3CompletedINTERVENTIONAL
Enrollment

360

Participants

Timeline

Start Date

November 1, 2017

Primary Completion Date

August 27, 2019

Study Completion Date

November 12, 2019

Conditions
Tinea Pedis
Interventions
DRUG

Dapaconazole

Application of 1 to 3 grams, depending on the lesion extension, per affected foot.

DRUG

Ketoconazole

Application of 1 to 3 grams, depending on the lesion extension, per affected foot.

Trial Locations (1)

Unknown

Galeno Desenvolvimento de Pesquisas Clinicas Ltda. - ME, Campinas

Sponsors
All Listed Sponsors
lead

Biolab Sanus Farmaceutica

INDUSTRY